• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

种族和民族差异对房颤患者的患病率、管理和结局的影响:系统评价。

Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review.

机构信息

Duke University Medical Center, Durham, North Carolina.

Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.

出版信息

Heart Rhythm. 2018 Sep;15(9):1337-1345. doi: 10.1016/j.hrthm.2018.05.019. Epub 2018 May 24.

DOI:10.1016/j.hrthm.2018.05.019
PMID:29803022
Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia in the United States and is associated with increased morbidity, mortality, and health care expenditures. In this review, our aim was to assess the racial and ethnic differences in the epidemiology, management, and outcomes of patients with AF. A search of relevant studies from January 1, 2007, to December 30, 2017, was conducted in PubMed, EMBASE, and Web of Science and supplemented by manual searches of the bibliographies of retrieved articles. We identified 152 studies of which 64 were subsequently included. We found that underrepresented racial and ethnic groups have a higher prevalence of established risk factors associated with the development of AF but an overall lower incidence and prevalence of AF as compared with non-Hispanic whites. Moreover, racial and ethnic differences exist in detection, awareness, and AF-associated symptoms. Nonwhite populations also experience decreased use of rhythm control modalities and anticoagulation for stroke prevention. Lastly, among those with AF, underrepresented racial and ethnic groups had increased morbidity and mortality relative to white groups. Racial and ethnic differences exist in the prevalence, quality of life, management, and outcomes of individuals with AF; however, the mechanisms for these differences have yet to be fully elucidated. Racial and ethnic differences in AF warrant further analysis to understand the factors contributing to the differences in prevalence and management to ensure the delivery of high quality care that prevents stroke, reduces deaths, and decreases expenses associated with caring for underrepresented populations with AF.

摘要

心房颤动(AF)是美国最常见的心律失常,与发病率、死亡率和医疗保健支出增加有关。在本次综述中,我们旨在评估 AF 患者在流行病学、管理和结局方面的种族和民族差异。我们在 PubMed、EMBASE 和 Web of Science 中检索了 2007 年 1 月 1 日至 2017 年 12 月 30 日的相关研究,并通过检索文章的参考文献进行了手工检索。我们确定了 152 项研究,其中 64 项随后被纳入。我们发现,代表性不足的种族和民族群体具有更高的与 AF 发展相关的既定风险因素的患病率,但与非西班牙裔白人相比,AF 的总体发病率和患病率较低。此外,在检测、认识和 AF 相关症状方面也存在种族和民族差异。非白人人群也较少使用节律控制方式和抗凝剂来预防中风。最后,在 AF 患者中,代表性不足的种族和民族群体的发病率和死亡率相对白人组更高。AF 患者的患病率、生活质量、管理和结局存在种族和民族差异;然而,这些差异的机制尚未完全阐明。AF 中的种族和民族差异需要进一步分析,以了解导致患病率和管理差异的因素,从而确保提供高质量的护理,预防中风,降低死亡率,并降低为代表性不足的 AF 人群提供护理相关的费用。

相似文献

1
Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review.种族和民族差异对房颤患者的患病率、管理和结局的影响:系统评价。
Heart Rhythm. 2018 Sep;15(9):1337-1345. doi: 10.1016/j.hrthm.2018.05.019. Epub 2018 May 24.
2
Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.心房颤动症状、治疗模式及结局的种族/民族差异:来自心房颤动更明智治疗结局登记处的见解
Am Heart J. 2016 Apr;174:29-36. doi: 10.1016/j.ahj.2015.10.028. Epub 2015 Dec 30.
3
Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: An Analysis Using Administrative Claims Data.患者多样性与人口健康相关的心血管结局与房颤患者使用华法林相关:使用行政索赔数据进行的分析。
Adv Ther. 2018 Nov;35(11):2069-2080. doi: 10.1007/s12325-018-0782-1. Epub 2018 Sep 15.
4
Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation.种族/族裔对华法林疗效的影响:对心房颤动患者预防中风的潜在意义。
CNS Drugs. 2008;22(10):815-25. doi: 10.2165/00023210-200822100-00003.
5
Racial Differences in Atrial Fibrillation Epidemiology, Management, and Outcomes.心房颤动在流行病学、管理及结局方面的种族差异。
Curr Treat Options Cardiovasc Med. 2019 Dec 10;21(12):85. doi: 10.1007/s11936-019-0793-5.
6
Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control.种族、民族和性别在心房颤动管理中的差异:心率和节律控制。
J Interv Card Electrophysiol. 2023 Aug;66(5):1279-1290. doi: 10.1007/s10840-022-01383-x. Epub 2022 Oct 13.
7
Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study).心房颤动抗凝治疗质量的种族差异(来自TREAT-AF研究)
Am J Cardiol. 2016 Jan 1;117(1):61-8. doi: 10.1016/j.amjcard.2015.09.047. Epub 2015 Oct 22.
8
Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation.种族对65岁以上房颤患者预后(中风和死亡)的影响。
Am J Cardiol. 2015 Jul 15;116(2):230-5. doi: 10.1016/j.amjcard.2015.04.012. Epub 2015 Apr 16.
9
Race and stroke in an atrial fibrillation inception cohort: Findings from the Penn Atrial Fibrillation Free study.种族与心房颤动发病队列中的中风:来自宾夕法尼亚房颤自由研究的结果。
Heart Rhythm. 2018 Apr;15(4):487-493. doi: 10.1016/j.hrthm.2017.11.025. Epub 2018 Feb 20.
10
Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.种族差异对心房颤动的认识和治疗:地理和种族差异导致中风的原因(REGARDS)研究。
Stroke. 2010 Apr;41(4):581-7. doi: 10.1161/STROKEAHA.109.573907. Epub 2010 Feb 26.

引用本文的文献

1
Racial and Ethnic Disparities in Catheter Ablation Utilization for Atrial Fibrillation: A Systematic Review and Meta-Analysis.心房颤动导管消融治疗中的种族和民族差异:一项系统评价和荟萃分析
JACC Adv. 2025 Aug 25;4(9):102105. doi: 10.1016/j.jacadv.2025.102105.
2
Evaluation of the treatment patterns among commercially insured patients with nonvalvular atrial fibrillation prescribed an oral anticoagulant by race/ethnicity.按种族/民族对开具口服抗凝剂的商业保险非瓣膜性心房颤动患者的治疗模式进行评估。
J Comp Eff Res. 2025 Sep;14(9):e250057. doi: 10.57264/cer-2025-0057. Epub 2025 Aug 5.
3
Racial/Ethnic Disparities in Anticoagulation for Atrial Fibrillation by Sex and Within High and Low Stroke Risk Populations.
按性别以及在高、低中风风险人群中,心房颤动抗凝治疗的种族/族裔差异。
J Innov Card Rhythm Manag. 2025 Jun 15;16(6):6330-6340. doi: 10.19102/icrm.2025.16062. eCollection 2025 Jun.
4
Demographic and Socio-Economic Disparities in the Outcomes Among Patients with NVAF Treated with Oral Anticoagulants: A Real-World Evaluation of Medicare Beneficiaries.口服抗凝剂治疗的非瓣膜性心房颤动患者结局的人口统计学和社会经济差异:医疗保险受益人的真实世界评估
J Clin Med. 2025 May 7;14(9):3252. doi: 10.3390/jcm14093252.
5
Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF.亚洲和非亚洲国家患者的房颤结局:来自GARFIELD-AF研究的见解
Open Heart. 2025 Feb 6;12(1):e003109. doi: 10.1136/openhrt-2024-003109.
6
Ethnic Differences in Atrial Fibrillation in the United Kingdom.英国心房颤动的种族差异
JACC Adv. 2024 Jul 3;3(12):101043. doi: 10.1016/j.jacadv.2024.101043. eCollection 2024 Dec.
7
Women and Atrial Fibrillation: Is the Disparity in Anticoagulation Just a Question of Gender? In Search of the Brazilian Reality.女性与心房颤动:抗凝治疗的差异仅仅是性别问题吗?探寻巴西的实际情况。
Arq Bras Cardiol. 2024 Nov 22;121(9):e20240583. doi: 10.36660/abc.20240583. eCollection 2024.
8
Racial and Ethnic Disparities in the Use and Outcomes With WATCHMAN FLX: A SURPASS Analysis of the NCDR Left Atrial Appendage Occlusion Registry.WATCHMAN FLX使用情况及治疗结果中的种族和民族差异:NCDR左心耳封堵注册研究的SURPASS分析
J Am Heart Assoc. 2024 Dec 3;13(23):e036406. doi: 10.1161/JAHA.124.036406. Epub 2024 Nov 22.
9
Atrial fibrillation in Black American patients: A review of genetics, risk factors, and outcomes.美国黑人患者的心房颤动:遗传学、危险因素及预后综述
Heart Rhythm. 2025 Mar;22(3):617-626. doi: 10.1016/j.hrthm.2024.10.074. Epub 2024 Nov 6.
10
Gender and contemporary risk of adverse events in atrial fibrillation.性别与心房颤动患者当代不良事件风险。
Eur Heart J. 2024 Sep 29;45(36):3707-3717. doi: 10.1093/eurheartj/ehae539.